New screening could stop dangerous pregnancy condition before it starts
NCT ID NCT07485140
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a new screening program during the first trimester can better identify pregnant women at risk for preeclampsia—a condition causing high blood pressure that can harm both mother and baby. Up to 80,000 women in Denmark will take part. Those found to be high risk will be offered daily low-dose aspirin to help prevent the condition. Researchers will compare rates of preterm preeclampsia before and after the program is introduced.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA (PE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University
RECRUITINGAarhus, 8200, Denmark
-
University of Copenhagen
RECRUITINGCopenhagen, 2100, Denmark
-
University of Copenhagen
RECRUITINGHillerød, 3400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common blood pressure drug protect the placenta in Early-Onset preeclampsia?
- Can a phone app slash pregnancy care costs? new study aims to find out
- New blood test could spot dangerous pregnancy condition early
- Pregnancy study seeks links between insulin resistance and placental problems
- Could a simple hormone improve preeclampsia outcomes?
- New study aims to uncover the secrets of preeclampsia in pregnant women